Skip to main content
Clinical Trials/NCT01219972
NCT01219972
Completed
Not Applicable

Prospective Cohort Study of Late Pulmonary Complications in Patients Who Received Allogeneic Hematopoietic Stem Cells Transplantation: Estimation of Incidence and Identification of Distinct Nosologic Entities

Assistance Publique - Hôpitaux de Paris1 site in 1 country245 target enrollmentJanuary 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Complications
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
245
Locations
1
Primary Endpoint
Non infectious pulmonary complication
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This is a prognostic study of the late lung complications arising at the patient's having received an allograft of hematopoetic stem cells.

Detailed Description

* Objectives To estimate the incidence of late (at least occurring 100 days after transplantation) pulmonary complications following allogeneic blood stem cells transplantation * Study Design Prospective Cohort Study All follow-up data were actualiized in September, 2016. * Sample Size 200 transplanted patients * Main Endpoint Non infectious pulmonary complications within the first 3 years

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
December 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Allogeneic Blood stem cell transplantation
  • Alive at day 100 post-transplant

Exclusion Criteria

  • Non informed consent

Outcomes

Primary Outcomes

Non infectious pulmonary complication

Time Frame: 3 years

Secondary Outcomes

  • Overall survival(3 years and 10 years)
  • Survival after non infectious pulmonary complication(3 years and 10 years)
  • Long term time course of Pulmonary Function Tests (PFTs)(3 years and 10 years)

Study Sites (1)

Loading locations...

Similar Trials